Magnus Financial Group LLC
Source: SEC Form 13F · as of Mar 2026Magnus Financial Group LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $20.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$20.8M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 6,516 | $6.0M |
| JNJJOHNSON & JOHNSON | 17,862 | $4.4M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 5,632 | $1.5M |
| ABBVAbbVie Inc. | 6,794 | $1.5M |
| TEVATeva Pharmaceutical Industries Limited | 38,084 | $1.1M |
| IMNMImmunome Inc. | 45,759 | $1.0M |
| PMPhilip Morris International Inc | 5,945 | $983K |
| MRKMerck & Co., Inc. | 7,376 | $887K |
| PFEPFIZER INC | 30,940 | $869K |
| AMGNAMGEN INC | 1,425 | $501K |
| NVSNovartis AG | 2,782 | $425K |
| ABTABBOTT LABORATORIES | 3,649 | $375K |
| AZNASTRAZENECA PLC | 1,877 | $370K |
| GMOptec International, Inc. | 4,474 | $333K |
| BMYBRISTOL MYERS SQUIBB CO | 4,960 | $301K |
| SNDLSNDL Inc. | 168,246 | $222K |
| SGMOSANGAMO THERAPEUTICS, INC | 10,000 | $2K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.